Mind Medicine has altered its state, rebranding as Definium Therapeutics ahead of a series of phase 3 data drops on its lead ...

Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol ...

Company on track to report topline results early in the second quarter of 2026 Second planned Data and Safety Monitoring Board (DSMB) meeting evaluated all available ...

Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1 ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

Detailed price information for Gh Research Plc (GHRS-Q) from The Globe and Mail including charting and trades.

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Company on track to report topline results early in the second quarter of 2026Second planned Data and Safety Monitoring Board ...

Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today provides a business update highlighting the Company's recent achievements in strengthening its product franchise and ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE and next-generation, highly selective ...

Caring for curly hair doesn’t have to be a chore. We tested over 100 shampoos to find the best products to keep curly hair ...

Introduction Visual Hallucinations (VHs) (seeing things that others do not, or visions) are a common feature of psychosis, causing significant distress and disability. Services rarely ask about these ...